Table 1.
Demographic characteristics of sporotrichosis patients and healthy control.
| total patients (n = 50) | Disease duration | Presentation | HC (n = 25) | |||
|---|---|---|---|---|---|---|
| duration <6 mon(n = 24; nFF = 12, nLF = 12) | Duration >6 mon(n = 26; nFF = 21, nLF = 5) | fixed form (n = 33; nSD = 12, nLD = 21) | lymphocutaneousform (n = 17; nSD = 12, nLD = 5) | |||
|
Age
(years, mean±SD) |
52 ± 13 | 48 ± 13 | 55 ± 12 | 51 ± 11 | 52 ± 15 | 53 ± 14 |
| Female/Male | 34/16 | 14/10 | 20/6 | 25/8 | 9/8 | 18/7 |
| Average duration (months, mean±SD) | 6.6 ± 5.2 | 2.6 ± 0.97 | 10.2 ± 4.8 | 7.6 ± 5.8 | 4.6 ± 3.2 | – |
The patients were No.1 to No.50 enrolled before 2020.07.10.